<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>patents on S Anand</title>
    <link>https://www.s-anand.net/blog/tag/patents/</link>
    <description>Recent content in patents on S Anand</description>
    <generator>Hugo -- 0.164.0</generator>
    <language>en-us</language>
    <lastBuildDate>Sun, 18 Mar 2007 12:00:00 +0000</lastBuildDate>
    <atom:link href="https://www.s-anand.net/blog/tag/patents/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>How Google Desktop ranks files</title>
      <link>https://www.s-anand.net/blog/how-google-desktop-ranks-files/</link>
      <pubDate>Sun, 18 Mar 2007 12:00:00 +0000</pubDate>
      <guid>https://www.s-anand.net/blog/how-google-desktop-ranks-files/</guid>
      <description>&lt;p&gt;Google filed a &lt;a href=&#34;http://www.freshpatents.com/Temporal-ranking-scheme-for-desktop-searching-dt20070222ptan20070043704.php?type=description&#34;&gt;patent for Google Desktop&lt;/a&gt; last month, that hints at how they rank search results. Last access time, where the item is stored, file type and file size are mentioned as factors, but there are probably some more left unmentioned.&lt;/p&gt;
</description>
    </item>
    <item>
      <title>Patents in the US healthcare industry</title>
      <link>https://www.s-anand.net/blog/patents-in-the-us-healthcare-industry/</link>
      <pubDate>Mon, 01 Nov 2004 12:00:00 +0000</pubDate>
      <guid>https://www.s-anand.net/blog/patents-in-the-us-healthcare-industry/</guid>
      <description>&lt;p&gt;Malcolm Gladwell on &lt;a href=&#34;http://newyorker.com/critics/atlarge/?041025crat_atlarge&#34;&gt;drug prices in the US&lt;/a&gt;.&lt;/p&gt;
&lt;blockquote&gt;
&lt;p&gt;AstraZeneca twenty-six billion dollars on Prilosec. The patent was due to expire. AstraZeneca decided on a subtle piece of chemical reengineering, creating a single isomer version. The new drug was called Nexium. The F.D.A. gave its blessing, and Nexium hit the pharmacy shelves priced at a hundred and twenty dollars for a month&amp;rsquo;s worth of pills.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;But the article goes on to show that the US drug industry isn&amp;rsquo;t necessarily overpriced.&lt;/p&gt;
</description>
    </item>
    <item>
      <title>W3C standards will be royalty free</title>
      <link>https://www.s-anand.net/blog/w3c-standards-will-be-royalty-free/</link>
      <pubDate>Fri, 21 Mar 2003 12:00:00 +0000</pubDate>
      <guid>https://www.s-anand.net/blog/w3c-standards-will-be-royalty-free/</guid>
      <description>&lt;p&gt;W3C&amp;rsquo;s making the first concrete, organised, meaningful move against intellectual property over-protection. &lt;a href=&#34;http://www.infoworld.com/article/03/03/19/HNpatent_1.html&#34;&gt;W3C standards will be royalty-free&lt;/a&gt;.&lt;/p&gt;
</description>
    </item>
    <item>
      <title>BountyQuest</title>
      <link>https://www.s-anand.net/blog/bountyquest/</link>
      <pubDate>Fri, 02 Feb 2001 12:00:00 +0000</pubDate>
      <guid>https://www.s-anand.net/blog/bountyquest/</guid>
      <description>&lt;p&gt;&lt;a href=&#34;http://www.bountyquest.com/&#34;&gt;BountyQuest&lt;/a&gt; is a place where companies post rewards for documents &amp;ndash; and anyone who comes up with such documents gets a prize. Many requests are for patent debunks.&lt;/p&gt;
</description>
    </item>
  </channel>
</rss>
